Better haemodynamic stability under xenon anaesthesia than under isoflurane anaesthesia during partial nephrectomy - a secondary analysis of a randomised controlled trial

Patrick Schäfer, Astrid Fahlenkamp, Rolf Rossaint, Mark Coburn, Ana Kowark, Patrick Schäfer, Astrid Fahlenkamp, Rolf Rossaint, Mark Coburn, Ana Kowark

Abstract

Background: Renal dysfunction following intraoperative arterial hypotension is mainly caused by an insufficient renal blood flow. It is associated with higher mortality and morbidity rates. We hypothesised that the intraoperative haemodynamics are more stable during xenon anaesthesia than during isoflurane anaesthesia in patients undergoing partial nephrectomy.

Methods: We performed a secondary analysis of the haemodynamic variables collected during the randomised, single-blinded, single-centre PaNeX study, which analysed the postoperative renal function in 46 patients who underwent partial nephrectomy. The patients received either xenon or isoflurane anaesthesia with 1:1 allocation ratio. We analysed the duration of the intraoperative systolic blood pressure decrease by > 40% from baseline values and the cumulative duration of a mean arterial blood pressure (MAP) of < 65 mmHg as primary outcomes. The secondary outcomes were related to other blood pressure thresholds, the amount of administered norepinephrine, and the analysis of confounding factors on the haemodynamic stability.

Results: The periods of an MAP of < 65 mmHg were significantly shorter in the xenon group than in the isoflurane group. The medians [interquartile range] were 0 [0-10.0] and 25.0 [10.0-47.5] minutes, for the xenon and isoflurane group, respectively (P = 0.002). However, the cumulative duration of a systolic blood pressure decrease by > 40% did not significantly differ between the groups (P = 0.51). The periods with a systolic blood pressure decrease by 20% from baseline, MAP decrease to values < 60 mmHg, and the need for norepinephrine, as well as the cumulative dose of norepinephrine were significantly shorter and lower, respectively, in the xenon group. The confounding factors, such as demographic data, surgical technique, or anaesthesia data, were similar in the two groups.

Conclusion: The patients undergoing xenon anaesthesia showed a better haemodynamic stability, which might be attributed to the xenon properties. The indirect effect of xenon anaesthesia might be of importance for the preservation of renal function during renal surgery and needs further elaboration.

Trial registration: ClinicalTrials.gov : NCT01839084. Registered 24 April 2013.

Keywords: Haemodynamic stability; Isoflurane; Nephroprotection; Renal function; Xenon.

Conflict of interest statement

MC and RR declare that they have received lecturer and consultant fees from Air Liquide Santé International. MC and RR declare that they have ongoing consultancy contracts with Air Liquide Santé International and Baxter. AK declares that she has received travel reimbursements by Air Liquide Santé International. PS and AF declare that they have no financial competing interests. All authors declare that they have no non-financial competing interests.

Figures

Fig. 1
Fig. 1
The flowcharta of this secondary analysis aThe flowchart was modified according to the PaNeX study for partial nephrectomy with xenon
Fig. 2
Fig. 2
Intraoperative heart rate Intraoperative heart rate in the xenon and isoflurane groups at different time points. The data were analysed using the Mann-Whitney U test and are presented as means ± standard deviation. *P-value < 0.05
Fig. 3
Fig. 3
Intraoperative norepinephrine consumption Cumulative intraoperative norepinephrine consumption in the xenon and isoflurane groups, presented as median with interquartile ranges. Individual data are presented as closed circles and squares. The data were analysed using the Mann-Whitney U test
Fig. 4
Fig. 4
Level of anaesthesia Level of anaesthesia measured by BIS monitoring in the xenon and isoflurane groups at different time points. BIS, bispectral index. The data were analysed using the Mann-Whitney U test and are presented as means ± standard deviation. *P-value < 0.05; **P-value < 0.01
Fig. 5
Fig. 5
Intraoperative systolic blood pressure Systolic blood pressure in the xenon and isoflurane groups at different time points. The data were analysed using the Mann-Whitney U test and are presented as means ± standard deviation. *P-value < 0.05; **P-value < 0.01

References

    1. Doehn C, Grunwald V, Steiner T, Follmann M, Rexer H, Krege S. The diagnosis, treatment, and follow-up of renal cell carcinoma. Dtsch Arztebl Int. 2016;113(35–36):590–596.
    1. Roggenbach Postoperatives Nierenversagen. Nephrologe. 2009;4:118–127. doi: 10.1007/s11560-008-0242-z.
    1. Brienza N, Giglio M, Marucci M, Fiore T. Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med. 2009;37(6):2079–2090. doi: 10.1097/CCM.0b013e3181a00a43.
    1. Agarwal R, Jain RK, Yadava A. Prevention of perioperative renal failure. Indian J Anaesth. 2008;52(1):38.
    1. Bläser D, Weiler N. Acute kidney injury--prevention, risk stratification and biomarkers. Anasthesiol Intensivmed Notfallmed Schmerzther. 2013;48:2.
    1. Lonjaret L, Lairez O, Minville V, Geeraerts T. Optimal perioperative management of arterial blood pressure. Integr Blood Press Control. 2014;7:49–59. doi: 10.2147/IBPC.S45292.
    1. Hallqvist L, Granath F, Huldt E, Bell M. Intraoperative hypotension is associated with acute kidney injury in noncardiac surgery. Eur J Anaesthesiol. 2018;35(4):273–279. doi: 10.1097/EJA.0000000000000735.
    1. Hallqvist L, Mårtensson J, Granath F, Sahlén A, Bell M. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: an observational study. Eur J Anaesthesiol. 2016;33(6):450–456. doi: 10.1097/EJA.0000000000000429.
    1. Salmasi V, Maheshwari K, Yang D, Mascha EJ, Singh A, Sessler DI, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac SurgeryA retrospective cohort analysis. Anesthesiology. 2017;126(1):47–65. doi: 10.1097/ALN.0000000000001432.
    1. van Waes JA, Van Klei WA, Wijeysundera DN, Van Wolfswinkel L, Lindsay TF, Beattie WS. Association between intraoperative hypotension and myocardial injury after vascular surgery. Anesthesiology. 2016;124(1):35–44. doi: 10.1097/ALN.0000000000000922.
    1. Wesselink E, Kappen T, Torn H, Slooter A, van Klei W. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth. 2018;121(4):706–721. doi: 10.1016/j.bja.2018.04.036.
    1. Bijker J, van Klei W, Kappen T, van Wolfswinkel L, Moons K, Kalkman C. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107(2):213–220. doi: 10.1097/01.anes.0000270724.40897.8e.
    1. Rossaint R, Coburn M. Choosing wisely in anesthesia : an important step in quality optimization. Anaesthesist. 2017;66:641–642. doi: 10.1007/s00101-017-0341-1.
    1. Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgerytoward an empirical definition of hypotension. Anesthesiology. 2013;119(3):507–515. doi: 10.1097/ALN.0b013e3182a10e26.
    1. De Deken J, Rex S, Monbaliu D, Pirenne J, Jochmans I. The efficacy of Noble gases in the attenuation of ischemia reperfusion injury: a systematic review and meta-analyses. Crit Care Med. 2016;44(9):e886–e896. doi: 10.1097/CCM.0000000000001717.
    1. Jia P, Teng J, Zou J, Fang Y, Zhang X, Bosnjak Z, et al. miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice. Anesthesiology. 2013;119(3):621–630. doi: 10.1097/ALN.0b013e318298e5f1.
    1. Ma D, Lim T, Xu J, Tang H, Wan Y, Zhao H, et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol. 2009;20(4):713–720. doi: 10.1681/ASN.2008070712.
    1. Rizvi M, Jawad N, Li Y, Vizcaychipi M, Maze M, Ma D. Effect of noble gases on oxygen and glucose deprived injury in human tubular kidney cells. Exp Biol Med (Maywood) 2010;235(7):886–891. doi: 10.1258/ebm.2010.009366.
    1. Smit K, Weber N, Hollmann M, Preckel B. Noble gases as cardioprotectants - translatability and mechanism. Br J Pharmacol. 2015;172(8):2062–2073. doi: 10.1111/bph.12994.
    1. Zhao H, Rossaint R, Coburn M, Ma D. Argon Organo-protective network a. the renoprotective properties of xenon and argon in kidney transplantation. Eur J Anaesthesiol. 2017;34(10):637–640. doi: 10.1097/EJA.0000000000000632.
    1. Zhao H, Watts H, Chong M, Huang H, Tralau-Stewart C, Maxwell P, et al. Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats. Am J Transplant. 2013;13(8):2006–2018. doi: 10.1111/ajt.12293.
    1. Bedi A, Murray J, Dingley J, Stevenson M, Fee J. Use of xenon as a sedative for patients receiving critical care. Crit Care Med. 2003;31(10):2470–2477. doi: 10.1097/01.CCM.0000089934.66049.76.
    1. Esencan E, Yuksel S, Tosun Y, Robinot A, Solaroglu I, Zhang J. XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia. Med Gas Res. 2013;3(1):4. doi: 10.1186/2045-9912-3-4.
    1. Höcker J, Grünewald M, Bein B. Xenon anaesthesia--clinical characteristics, benefits and disadvantages and fields of application. Anasthesiol Intensivmed Notfallmed Schmerzther. 2012;47(6):374–380. doi: 10.1055/s-0032-1316478.
    1. Stevanovic A, Schaefer P, Coburn M, Rossaint R, Stoppe C, Boor P, et al. Renal function following xenon anesthesia for partial nephrectomy-an explorative analysis of a randomized controlled study. PLoS One. 2017;12(7):e0181022. doi: 10.1371/journal.pone.0181022.
    1. Brücken A, Coburn M, Rex S, Rossaint R, Fries M. Current developments in xenon research. Importance for anesthesia and intensive care medicine. Anaesthesist. 2010;59(10):883–895. doi: 10.1007/s00101-010-1787-6.
    1. Deile M, Damm M, Heller A. Inhaled anesthetics. Anaesthesist. 2013;62(6):493–504. doi: 10.1007/s00101-013-2175-9.
    1. Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M. Xenon: recent developments and future perspectives. Minerva Anestesiol. 2009;75(1–2):37–45.
    1. Torri G. Inhalation anesthetics: a review. Minerva Anestesiol. 2010;76(3):215–228.
    1. Futier E, Lefrant J-Y, Guinot P-G, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. Jama. 2017;318(14):1346–1357. doi: 10.1001/jama.2017.14172.
    1. Romagnoli S, Ricci Z, Ronco C. Perioperative acute kidney injury: prevention, early recognition, and supportive measures. Nephron. 2018;140(2):105–110. doi: 10.1159/000490500.
    1. Aronson S, Mythen MG. Perioperative Management of High-Risk Patients: going beyond “avoid hypoxia and hypotension”. Jama. 2017;318(14):1330–1332. doi: 10.1001/jama.2017.13699.
    1. Neukirchen M, Hipp J, Schaefer M, Brandenburger T, Bauer I, Winterhalter M, et al. Cardiovascular stability and unchanged muscle sympathetic activity during xenon anaesthesia: role of norepinephrine uptake inhibition. Br J Anaesth. 2012;109(6):887–896. doi: 10.1093/bja/aes303.
    1. Hofland J, Ouattara A, Fellahi J-L, Gruenewald M, Hazebroucq J, Ecoffey C, et al. Effect of xenon anesthesia compared to sevoflurane and Total intravenous anesthesia for coronary artery bypass graft surgery on postoperative cardiac troponin ReleaseAn international, multicenter, phase 3, single-blinded, randomized noninferiority trial. Anesthesiology. 2017;127(6):918–933. doi: 10.1097/ALN.0000000000001873.
    1. Rossaint R, Reyle-Hahn M, am Esch JS, Scholz J, Scherpereel P, Vallet B, et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology. 2003;98(1):6–13. doi: 10.1097/00000542-200301000-00005.
    1. Al Tmimi L, Devroe S, Dewinter G, Van de Velde M, Poortmans G, Meyns B, et al. Xenon as an adjuvant to Propofol anesthesia in patients undergoing off-pump coronary artery bypass graft surgery: a pragmatic randomized controlled clinical trial. Anesth Analg. 2017;125(4):1118–1128. doi: 10.1213/ANE.0000000000002179.
    1. Fleisher L, Fleischmann K, Auerbach A, Barnason S, Beckman J, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;130(24):e278–e333.
    1. Roshanov P, Rochwerg B, Patel A, Salehian O, Duceppe E, Belley-Côté E, et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patIents cOhort evaluatioN prospective cohort. Anesthesiology. 2017;126(1):16–27. doi: 10.1097/ALN.0000000000001404.
    1. Walker S, Abbott T, Brown K, Pearse R, Ackland G. Perioperative management of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers: a survey of perioperative medicine practitioners. PeerJ. 2018;6:e5061. doi: 10.7717/peerj.5061.
    1. Ohashi N, Isobe S, Ishigaki S, Suzuki T, Motoyama D, Sugiyama T, et al. The effects of unilateral nephrectomy on blood pressure and its circadian rhythm. Intern Med. 2016;55(23):3427–3433. doi: 10.2169/internalmedicine.55.7215.
    1. Baumert J-H. Xenon-based anesthesia: theory and practice. Open Access Surgery. 2009;2:5–13. doi: 10.2147/OAS.S4592.
    1. Giacalone M, Abramo A, Giunta F, Forfori F. Xenon-related analgesia: a new target for pain treatment. Clin J Pain. 2013;29(7):639–643. doi: 10.1097/AJP.0b013e31826b12f5.
    1. Coburn M, Kunitz O, Baumert J-H, Hecker K, Haaf S, Zühlsdorff A, et al. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth. 2004;94(2):198–202. doi: 10.1093/bja/aei023.
    1. Devroe S, Lemiere J, Van de Velde M, Gewillig M, Boshoff D, Rex S. Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial. Trials. 2015;16(1):74. doi: 10.1186/s13063-015-0587-3.
    1. Wappler F, Rossaint R, Baumert J, Scholz J, Tonner PH, van Aken H, et al. Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery. Anesthesiology. 2007;106(3):463–471. doi: 10.1097/00000542-200703000-00010.
    1. Kirkland LL. Protecting both heart and brain: a noble goal for a noble gas. Crit Care Med. 2013;41(9):2228–2229. doi: 10.1097/CCM.0b013e31828fd750.
    1. Al Tmimi L, Van Hemelrijck J, Van De Velde M, Sergeant P, Meyns B, Missant C, et al. Xenon anaesthesia for patients undergoing off-pump coronary artery bypass graft surgery: a prospective randomized controlled pilot trial. BJA: Br J Anaesth. 2015;115(4):550–559. doi: 10.1093/bja/aev303.
    1. Stapelfeldt WH, Yuan H, Dryden JK, Strehl KE, Cywinski JB, Ehrenfeld JM, et al. The SLUScore: a novel method for detecting hazardous hypotension in adult patients undergoing noncardiac surgical procedures. Anesth Analg. 2017;124(4):1135. doi: 10.1213/ANE.0000000000001797.

Source: PubMed

3
Abonner